Docusign
DOCU
$69.07
-2.22%
DocuSign, Inc. operates in the Technology sector within the Software - Application industry, providing the Agreement Cloud — a broad cloud-based software suite that enables users to automate the agreement process and deliver legally binding e-signatures from nearly any device. Founded in 2003 and publicly listed in 2018, the company has evolved from a pure-play e-signature vendor into a broader agreement-management platform, employing roughly 7,044 people and commanding a market capitalization of approximately $10.5 billion. The current investor narrative centers on a tension between improving profitability and decelerating top-line growth: recent quarterly results showed revenue growth of just 8.7% year-over-year, yet the company continues to expand margins and generate substantial free cash flow, prompting debate over whether DocuSign is a maturing cash cow or a platform still capable of re-accelerating. Management's decision to raise its long-term outlook while analysts trimmed price targets — as reflected in the June 2026 sell-off despite strong earnings — encapsulates the market's focus on valuation and the durability of future growth. The stock's sharp three-month rally of nearly 59% against a still-negative one-year return further illustrates the tug-of-war between momentum traders and longer-term skeptics.…
DOCU
Docusign
$69.07
Related headlines
DOCU 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Docusign's 12-month outlook, with a consensus price target around $69.29 and implied upside of +0.3% versus the current price.
Average Target
$69.29
0 analysts
Implied Upside
+0.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$47 - $86
Analyst target range
DocuSign is covered by 17 analysts, with a consensus recommendation of "hold" and a recommendation mean of 2.75 (where 1 is Strong Buy and 5 is Strong Sell). The average price target is $69.29, which implies essentially zero upside from the current price of $69.07 — the stock is trading almost exactly at consensus fair value. This neutral stance is corroborated by the institutional ratings data, which shows a heavy skew toward Hold/Neutral/Equal Weight ratings from firms including Citigroup, Jefferies, Needham, Wells Fargo, and Wedbush, with only BTIG maintaining a Buy rating. The consensus is decidedly neutral, reflecting analyst uncertainty about whether the recent rally is sustainable or has already priced in the company's improved outlook.
The target range spans from a low of $46.89 to a high of $86.00, a spread of roughly 83% that signals significant disagreement about DocuSign's trajectory. The high target of $86.00 — approximately 24% above the current price — likely assumes successful execution on the raised long-term outlook, continued margin expansion, and possibly multiple re-rating as the market recognizes the company's cash generation. The low target of $46.89 — roughly 32% below current levels — prices in concerns about growth deceleration, competitive pressure in the e-signature market, and the risk that the recent rally was overdone. Notably, Citigroup downgraded the stock from Buy to Neutral in April 2026, and the June 2026 earnings report saw multiple firms lower price targets despite strong results, suggesting a pattern of analysts trimming expectations even as the stock rallied. The wide target spread, combined with the recent downgrade activity and the stock trading at consensus fair value, indicates low conviction among analysts and elevated uncertainty — a setup that could lead to sharp moves in either direction depending on upcoming earnings and guidance.
Bulls vs Bears: DOCU Investment Factors
The bull case rests on DocuSign's deeply discounted forward PE of 13.27x, expanding operating margins (now 13.4%), and robust free cash flow generation of $1.12 billion. The bear case emphasizes decelerating revenue growth at 8.7%, a consensus 'hold' rating with zero implied upside to the average target, and a still-negative 1-year return of -18.75%. Currently, the bear evidence appears slightly stronger given the lack of analyst conviction and growth concerns, but the bull case has momentum. The single most important tension is whether DocuSign can re-accelerate revenue growth or if it will remain a mature, slow-growth cash cow; resolution of this will determine whether the stock re-rates higher or remains range-bound.
Bullish
- Forward PE of 13.3x is deeply discounted: The forward PE of 13.27x is less than half the trailing PE of 34.57x, implying the market expects EPS to surge to $5.73 from a distorted trailing base. This multiple is well below the software sector average and suggests significant undervaluation if earnings normalize as analysts project.
- Operating margin expansion from 8.1% to 13.4%: Operating margin has expanded from 8.1% in Q2 FY2025 to 13.4% in the latest quarter, demonstrating strong cost discipline and operating leverage. This 530 basis point improvement occurred despite revenue growth of only 8.7%, highlighting management's ability to drive profitability even in a slower-growth environment.
- Robust free cash flow of $1.12 billion TTM: DocuSign generated $1.12 billion in trailing twelve-month free cash flow, with a healthy 90% conversion from operating cash flow. This cash generation supports aggressive share buybacks ($317.5 million in the latest quarter) and provides ample financial flexibility with virtually no debt (debt-to-equity of 0.097).
- Analyst high target implies 24% upside: The highest analyst price target of $86.00 represents approximately 24% upside from the current price of $69.07. While the consensus average target of $69.29 suggests fair value, the wide target range (low of $46.89 to high of $86.00) indicates that some analysts see substantial upside if the company executes on its raised long-term outlook.
Bearish
- Revenue growth decelerating to 8.7% YoY: Revenue growth has slowed to just 8.72% year-over-year in the latest quarter, a far cry from the hypergrowth era that once justified premium multiples. This deceleration raises concerns about the company's ability to re-accelerate growth and justify its valuation.
- Stock trading at consensus fair value: The average analyst target of $69.29 is virtually identical to the current price of $69.07, implying zero upside. With a consensus recommendation of 'hold' and a recommendation mean of 2.75, analysts see limited near-term upside and are waiting for clearer growth signals.
- Current ratio of 0.73 signals liquidity tightness: The current ratio of 0.73 indicates that current liabilities exceed current assets, which could pose a short-term liquidity risk if not managed properly. While typical for software companies with deferred revenue, it warrants monitoring.
- Analyst downgrades and target cuts despite strong earnings: Despite reporting strong earnings and raising its long-term outlook, DocuSign's stock fell in June 2026 as analysts lowered price targets, signaling investor focus on valuation and future growth pace. Citigroup downgraded the stock from Buy to Neutral in April 2026, reflecting growing skepticism.
DOCU Technical Analysis
DocuSign is in a powerful recovery uptrend that contrasts sharply with its longer-term performance. The stock's 1-year price change stands at -18.75%, yet the current price of $69.07 sits at approximately 63% of its 52-week range (low of $40.16, high of $86.27), indicating the shares have rebounded substantially from their lows but remain well below their peak. This positioning suggests the stock is in a momentum-driven recovery phase rather than a fully extended breakout, with the 52-week high still roughly 25% above current levels. The 6-month gain of 46.24% and year-to-date advance of 6.51% confirm that the intermediate trend has turned decisively positive even as the trailing 12-month picture remains negative.
Recent momentum is strongly positive and accelerating. The 1-month price change of +11.21% and 3-month change of +58.89% show a dramatic surge, with the 3-month figure vastly outpacing the 6-month gain of 46.24%, implying most of the rally occurred in the last quarter. This creates a notable divergence from the 1-year trend of -18.75%, which could signal either a genuine trend reversal driven by improving fundamentals or a sharp mean-reversion bounce that may be vulnerable to profit-taking. Relative strength versus the S&P 500 is striking: +56.89% over 3 months and +12.17% over 1 month, though the 1-year relative strength of -33.76% underscores how much ground the stock is still recovering. The most recent session saw a -2.22% pullback on volume of 7.16 million shares, a modest consolidation after the run.
Key technical levels are well-defined. Support rests at the 52-week low of $40.16, with secondary support likely near the $60 psychological zone where the stock consolidated in August; resistance sits at the 52-week high of $86.27, and a breakout above the recent $71.85 intraday peak would confirm continuation of the uptrend. A breakdown below $60 would signal the rally is losing steam and could expose the stock to a retest of the mid-$50s. With a beta of 0.90, DocuSign is slightly less volatile than the broader market, meaning its dramatic 3-month move is driven by stock-specific catalysts rather than market beta — a factor that favors position sizing based on idiosyncratic risk rather than broad market hedging. The maximum drawdown of -50.89% over the period serves as a reminder of the stock's historical vulnerability to sharp reversals.
Beta
0.90
0.90x market volatility
Max Drawdown
-50.9%
Largest decline past year
52-Week Range
$40-$86
Price range past year
Annual Return
-18.8%
Cumulative gain past year
| Period | DOCU Return | S&P 500 |
|---|---|---|
| 1m | +11.2% | -0.5% |
| 3m | +58.9% | +2.3% |
| 6m | +46.2% | +16.6% |
| 1y | -18.8% | +14.8% |
| ytd | +6.5% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DOCU Fundamental Analysis
DocuSign's revenue trajectory shows steady but decelerating growth. The most recent quarter (ending 2026-04-30) delivered revenue of $830.2 million, up 8.72% year-over-year from $763.7 million in the prior-year quarter. The multi-quarter trend reveals a company growing in the high-single-digit range: Q4 FY2026 revenue was $836.9 million, Q3 was $818.4 million, and Q2 was $800.6 million, each representing modest sequential gains. Segment data shows subscription and circulation revenue of $811.2 million dwarfing professional services and other at $19.0 million, confirming the business is overwhelmingly recurring-revenue driven — a positive for predictability but also a sign that new growth vectors remain nascent. The 8.7% growth rate is respectable for a mature software company but far below the hypergrowth era that once justified premium multiples, and the investment case now hinges on whether margin expansion and cash generation can offset slowing topline momentum.
Profitability is solid and improving. The company reported net income of $78.2 million in the latest quarter, translating to a net margin of 9.6%, while gross margin remains exceptionally high at 79.4% — a hallmark of software economics. Operating margin came in at 13.4% for the quarter, up from 10.5% in Q4 FY2026 and 8.1% in Q2 FY2025, demonstrating meaningful operating leverage as the company controls costs. EBITDA for the quarter was $150.5 million with an EBITDA ratio of 18.1%, and the trailing ROE of 16.1% and ROA of 6.35% indicate efficient capital deployment. The margin trajectory — from sub-8% operating margins a year ago to 13.4% now — is the strongest part of the fundamental story and suggests management's cost discipline is bearing fruit even as revenue growth moderates.
Balance sheet and cash flow metrics are robust. Debt-to-equity is remarkably low at 0.097, and the interest coverage ratio of 202x reflects negligible financial leverage risk. Free cash flow on a trailing 12-month basis is $1.12 billion, with the latest quarter generating $289.4 million in FCF against $321.7 million in operating cash flow, a healthy 90% conversion rate. However, the current ratio of 0.73 raises a short-term liquidity flag — current liabilities exceed current assets — though this is typical for software companies that carry large deferred revenue balances. The company returned capital aggressively, repurchasing $317.5 million of stock in the quarter, funded entirely from internal cash generation. With $565.7 million in cash at period end and no meaningful debt burden, DocuSign has ample financial flexibility to fund growth initiatives, buybacks, or strategic acquisitions without external financing.
Quarterly Revenue
$830235000.0B
2026-04
Revenue YoY Growth
+8.7%
YoY Comparison
Gross Margin
79.4%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DOCU Overvalued?
Because DocuSign is profitable with positive net income of $78.2 million in the latest quarter, the PE ratio is the appropriate primary valuation metric. The trailing PE stands at 34.57x, while the forward PE is dramatically lower at 13.27x — a gap that implies the market expects substantial earnings growth ahead. This forward multiple compression reflects analyst consensus EPS estimates of $5.73 for the coming year, which would represent a massive increase from the trailing EPS of $0.029 (a figure distorted by a one-time tax-related gain in the prior-year period). The wide spread between trailing and forward PE signals that the market is pricing in a normalization of earnings rather than a structural deterioration, though the reliability of that forward estimate warrants scrutiny given the company's modest net margin.
On a peer-relative basis, DocuSign's valuation presents a mixed picture. Its PS ratio of 3.27x and EV/Sales of 3.75x are relatively modest for a software company with 79% gross margins, suggesting the stock trades at a discount to high-growth SaaS peers that often command 8-15x sales. However, the EV/EBITDA of 17.99x and price-to-free-cash-flow of 9.04x indicate the market is not pricing DocuSign as a distressed asset. The PEG ratio of -0.49 is not meaningful due to the distorted trailing earnings base. Compared to the broader application software industry, DocuSign's 3.27x PS ratio likely represents a discount to the sector median, which is arguably justified by its high-single-digit growth rate versus the low-to-mid-teens growth typical of premium SaaS names — the company is priced as a value-oriented software stock, not a growth leader.
Historical context is instructive. DocuSign's PS ratio has compressed dramatically from levels above 20x in 2023 and 2024 (reaching 21.76x in Q1 FY2026 and 25.33x in Q4 FY2025) to the current 3.27x — a roughly 85% multiple contraction. Similarly, the PE ratio has fallen from over 58x in early 2025 to 34.57x trailing today. This places the stock near the bottom of its own historical valuation band, which could signal either a compelling value opportunity or a permanent de-rating reflecting the market's reassessment of DocuSign's growth ceiling. The PB ratio of 5.49x is also well below historical peaks above 9x, reinforcing that the stock is trading at a substantial discount to its own history — a setup that favors value-oriented investors if growth can stabilize, but one that has repeatedly disappointed momentum investors over the past two years.
PE
34.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 3x~117x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.0x
Enterprise Value Multiple
Investment Risk Disclosure
DocuSign's financial risks are relatively contained but not negligible. The company carries minimal debt with a debt-to-equity ratio of 0.097 and an interest coverage ratio of 202x, virtually eliminating solvency concerns. However, the current ratio of 0.73 indicates that current liabilities exceed current assets, which could strain short-term liquidity if deferred revenue declines or operating cash flow weakens. Additionally, revenue growth has decelerated to 8.7% year-over-year, and with 97.7% of revenue from subscription services, any slowdown in customer additions or renewals could disproportionately impact results. The company's net margin of 9.6% is modest, and while operating margins are improving, further expansion may be challenging if growth remains sluggish.
Market and competitive risks are significant. DocuSign trades at a forward PE of 13.27x, which is low relative to historical levels but could remain depressed if growth fails to accelerate. The stock's beta of 0.90 suggests it is slightly less volatile than the market, but its 3-month rally of 58.9% was driven by idiosyncratic factors, making it vulnerable to profit-taking. Competition in the e-signature and agreement management space is intensifying, with rivals like Adobe and emerging startups pressuring pricing and innovation. Regulatory headwinds, such as potential changes to e-signature laws or data privacy regulations, could also impact operations. Recent news highlights that despite strong earnings, analysts lowered price targets, indicating concerns about future growth pace and valuation.
The worst-case scenario for DocuSign would involve a combination of decelerating revenue growth, margin compression, and multiple contraction. If revenue growth falls below 5% and operating margins stall, the stock could retest its 52-week low of $40.16, representing a decline of approximately 42% from the current price of $69.07. The analyst low target of $46.89 implies a 32% downside, and the maximum drawdown over the past period was -50.89%. Such a scenario could be triggered by a recession reducing enterprise software spending, competitive losses, or a failure to monetize new products. Investors could lose over 40% in this adverse scenario, underscoring the importance of risk management.